Coronary Plaque, Inflammation, Subclinical Myocardial Injury, and Major Adverse Cardiovascular Events in the REPRIEVE Substudy

By sjmartinez • May 17, 2025

Lu MT, Ribaudo HJ, McCallum S, Zanni MV, deFilippi C, Taron J, Karady J, Foldyna B, Paradis K, Chu SM, Diggs MR, Burdo TH, Currier JS, Bloomfield GS, Fichtenbaum CJ, Malvestutto CD, Aberg JA, Mayrhofer T, Douglas PS, Grinspoon SK; REPRIEVE Investigators. Coronary Plaque, Inflammation, Subclinical Myocardial Injury, and Major Adverse Cardiovascular Events in the REPRIEVE Substudy. JACC Adv. 2025 May 14;4(6 Pt 1):101781. doi: 10.1016/j.jacadv.2025.101781. Epub ahead of print. PMID: 40373520.

Tags: biomarkers, coronary plaque, HIV, Infectious Diseases, Inflammation, major adverse cardiovascular events, myocardial injury, Publications

Use of DNA profiling to resolve HIV status in a person using injectable cabotegravir for HIV pre-exposure prophylaxis

Fogel JM, Salih MA, Haddaway K, Marzinke MA, Marshall C, Wang Z, Cummings V, Piwowar-Manning E, Rooney JF, McCauley M, Grinsztejn B, Landovitz RJ, Eshleman[...]

Adding Intranasal to Oral Administration of an Ultra-rapid Near Universal Drug Regimen Accelerates Relapse-free Cure of Tuberculosis in Mice

Lee BY, Clemens DL, Masleša-Galic S, Nava S, Lo CY, Zink JI, Horwitz MA. Adding Intranasal to Oral Administration of an Ultra-rapid Near Universal Drug[...]

Metrics Selection and Risk Adjustment Methods to Benchmark Inpatient Antibiotic Use

Goto M, Cho H, Merchant JA, Perencevich EN, Goetz MB, Marra AR, Alexander B, Hanks TC, Beck BF, Richards C, Hernandez DM, Livorsi DJ. Metrics[...]